Preliminary results of a phase I clinical trial using an autologous dendritic cell cancer vaccine targeting HER2 in patients with metastatic cancer or operated high-risk bladder cancer (NCT01730118).Hoyoung Maeng, Jay A. Berzofsky, Lee England et al.|Journal of Clinical Oncology|2019Cited by 8